Ernexa Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $6.0M | $31.5M | $17.0M |
| FY2022 | $10.2M | $22.3M | $11.4M |
| FY2023 | $46.9M | $49.1M | $7.6M |
| FY2024 | $3.6M | $5.3M | $1.7M |
| FY2025 | $3.4M | $5.8M | $1.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $6.0M | $31.5M | $17.0M |
| FY2022 | $10.2M | $22.3M | $11.4M |
| FY2023 | $46.9M | $49.1M | $7.6M |
| FY2024 | $3.6M | $5.3M | $1.7M |
| FY2025 | $3.4M | $5.8M | $1.9M |